DERMAGRAFT

FDA Premarket Approval P000036 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a change in the caution statement in the directions for use from "do not use dermagraft after the expiration date" to "do not use dermagraft after the expiration date indicated on the labeled unit carton. "

DeviceDERMAGRAFT
Generic NameDressing, Wound And Burn, Interactive
ApplicantSHIRE REGENERATIVE MEDICINE
Date Received2002-03-05
Decision Date2002-03-19
PMAP000036
SupplementS002
Product CodeMGR 
Advisory CommitteeGeneral & Plastic Surgery
Supplement TypeSpecial (immediate Track)
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address SHIRE REGENERATIVE MEDICINE 11095 Torreyana Road san Diego, CA 92121

Supplemental Filings

Supplement NumberDateSupplement Type
P000036Original Filing
S018 2013-04-25 30-day Notice
S017 2013-04-24 30-day Notice
S016 2013-04-23 30-day Notice
S015
S014 2012-12-21 135 Review Track For 30-day Notice
S013 2012-06-29 30-day Notice
S012 2012-06-05 30-day Notice
S011 2012-04-23 135 Review Track For 30-day Notice
S010 2012-03-16 30-day Notice
S009 2012-03-16 30-day Notice
S008 2012-03-13 Normal 180 Day Track No User Fee
S007 2010-03-02 30-day Notice
S006 2008-10-31 30-day Notice
S005
S004
S003 2003-11-17 Special (immediate Track)
S002 2002-03-05 Special (immediate Track)
S001

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.